SF
MED icon

Synovus Financial’s Medifast MED Stock Holding History

Synovus Financial’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-109
Closed -$7K – 1901
2020
Q1 		$7K Buy
109
+89
+445% +$8.1K ﹤0.01% 1684
2019
Q4 		$2K Sell
20
-20
-50% -$1.94K ﹤0.01% 1431
2019
Q3 		$4K Hold
40
– – ﹤0.01% 1321
2019
Q2 		$5K Buy
+40
New +$5.56K ﹤0.01% 1223

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Synovus Financial's MED Position: Q2 2020 in Review

Synovus Financial sold out of Medifast (MED) in Q2 2020, closing a stake of 109 shares — an estimated $7K sold.

Synovus Financial first reported a position in MED in Q2 2019 and held it in 4 quarters. The position peaked at $7K in Q1 2020. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

  • Synovus Financial reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 109 Medifast shares in Q2 2020, an estimated $7K.
  • Synovus Financial first reported a position in Medifast in Q2 2019 and held it in 4 quarters.
  • Synovus Financial's Medifast position peaked at $7K in Q1 2020.
  • 224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.